[HTML][HTML] Metastatic disease in head & neck oncology
P Pisani, M Airoldi, A Allais, PA Valletti… - Acta …, 2020 - ncbi.nlm.nih.gov
The head and neck district represents one of the most frequent sites of cancer, and the
percentage of metastases is very high in both loco-regional and distant areas. Prognosis …
percentage of metastases is very high in both loco-regional and distant areas. Prognosis …
[HTML][HTML] The molecular basis and therapeutic aspects of cisplatin resistance in oral squamous cell carcinoma
Y Cheng, S Li, L Gao, K Zhi, W Ren - Frontiers in oncology, 2021 - frontiersin.org
Oral squamous cell carcinoma (OSCC) is a kind of malignant tumors with low survival rate
and prone to have early metastasis and recurrence. Cisplatin is an alkylating agent which …
and prone to have early metastasis and recurrence. Cisplatin is an alkylating agent which …
Oral squamous cell carcinoma: current treatment strategies and nanotechnology-based approaches for prevention and therapy
Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer; it involves
damage to oral epithelial cells due to accumulation of multiple genetic mutations in the cells …
damage to oral epithelial cells due to accumulation of multiple genetic mutations in the cells …
[HTML][HTML] Optimal treatment for recurrent/metastatic head and neck cancer
JB Vermorken, P Specenier - Annals of oncology, 2010 - Elsevier
While a large proportion of patients presenting with stage I and II squamous cell carcinoma
of the head and neck (SCCHN) will remain disease free after single modality treatment, the …
of the head and neck (SCCHN) will remain disease free after single modality treatment, the …
[HTML][HTML] The diagnosis and treatment of oral cavity cancer
KD Wolff, M Follmann, A Nast - Deutsches Ärzteblatt International, 2012 - ncbi.nlm.nih.gov
Background About 10 000 persons are diagnosed as having carcinoma of the oral cavity or
the throat in Germany every year. Squamous-cell carcinoma accounts for 95% of cases …
the throat in Germany every year. Squamous-cell carcinoma accounts for 95% of cases …
Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy
S Furness, AM Glenny, HV Worthington… - Cochrane Database …, 2011 - cochranelibrary.com
Background Oral cavity and oropharyngeal cancers are frequently described as part of a
group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally …
group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally …
[HTML][HTML] A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma
M Tahara, S Okano, T Enokida, Y Ueda… - International Journal of …, 2021 - Springer
Background To determine the safety, preliminary efficacy, pharmacokinetics, and
immunogenicity of a single cycle of RM-1929 photoimmunotherapy, an anti-EGFR antibody …
immunogenicity of a single cycle of RM-1929 photoimmunotherapy, an anti-EGFR antibody …
MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
Chemotherapy has been reported to induce epithelial-mesenchymal transition (EMT) in
tumor cells, which is a critical step in the process of metastasis leading to cancer spreading …
tumor cells, which is a critical step in the process of metastasis leading to cancer spreading …
Current treatment options for metastatic head and neck cancer
KAR Price, EE Cohen - Current treatment options in oncology, 2012 - Springer
Opinion statement Head and neck squamous cell carcinoma is now the 8th most common
cancer affecting men in the United States largely due to a rising epidemic of oropharynx …
cancer affecting men in the United States largely due to a rising epidemic of oropharynx …
Chemotherapy for oral cancer
L Hartner - Dental Clinics, 2018 - dental.theclinics.com
The past several years have seen major advances in the use of systemic therapy for
treatment of patients with oral cancer. Systemic therapy refers to chemotherapy and …
treatment of patients with oral cancer. Systemic therapy refers to chemotherapy and …